{"id":2421,"date":"2025-06-16T15:55:11","date_gmt":"2025-06-16T14:55:11","guid":{"rendered":"https:\/\/www.sedapds.com\/news\/"},"modified":"2025-06-23T10:17:31","modified_gmt":"2025-06-23T09:17:31","slug":"seda-wins-prestigious-medilink-award-for-outstanding-achievement","status":"publish","type":"post","link":"https:\/\/www.sedapds.com\/news\/seda-wins-prestigious-medilink-award-for-outstanding-achievement\/","title":{"rendered":"Seda Wins Medilink Award for Outstanding Achievement"},"content":{"rendered":"

Seda are thrilled to announce that we\u00a0have been awarded<\/a> the Medilink Award for Outstanding Achievement, in recognition of the launch of Seda Clinical Manufacturing Services division with state-of-the-art GMP facility<\/a>.<\/span>\u00a0<\/span><\/p>\n

This inception integrates model-informed formulation design, clinical pharmacology services and GMP manufacturing, creating a seamless service for optimised dosage forms. This innovative integration speeds up the delivery of investigational medicines, improving efficiency and reducing development timelines. Additionally, Seda designed bespoke quality systems tailored to early-phase clinical manufacturing, integrating regulatory compliance with operational flexibility for rapid project execution.\u00a0 The launch of Seda Clinical Manufacturing Services<\/a> has significantly enhanced our end-to-end pharmaceutical development capabilities, accelerating drug development timelines, especially critical in oncology.\u00a0<\/span>\u00a0<\/span><\/p>\n

Seda’s bespoke quality system ensures rapid project execution while ensuring full compliance with GMP standards. This transformative step sets Seda apart by providing a comprehensive solution for global biotechs, driving innovation and boosting the UK\u2019s global standing in life sciences. Addressing the need for agile, small-scale, early-phase GMP manufacturing and creating 100 high-skilled jobs, Seda reinforces Manchester\u2019s reputation as a thriving biotech hub, contributing to the region’s economic growth and scientific advancements.<\/span>\u00a0<\/span><\/p>\n

Seda\u2019s partnership with Santander<\/a> NW involved meticulous planning and development. The \u00a38.5 million investment, supported by a \u00a35.5 million flexibly structured loan, was strategically aligned with construction and commissioning milestones. Santander\u2019s phased disbursement plan ensured funding was available when needed, while full interest accrued only on drawn down funds. This innovative financing strategy mitigated revenue downtime challenges pre-MHRA inspection. Opting for bank financing over VC or PE funding allowed Seda to retain operational autonomy.<\/span>\u00a0<\/span><\/p>\n

This award highlights Seda\u2019s unwavering commitment to uphold high-quality standards and innovative solutions through cutting-edge technology, sustainable practices, and a relentless focus on quality and impact.<\/span>\u00a0<\/span><\/p>\n

The Medilink Awards are known for spotlighting organisations that demonstrate exceptional performance, and this accolade is a testament to the dedication, creativity, and hard work of the entire Seda team.<\/span>\u00a0<\/span><\/p>\n

Receiving the Outstanding Achievement Award is not only a proud moment for us but also a powerful motivator to continue pushing boundaries and delivering meaningful change in the industry. We would like to thank Medilink and all our partners, clients, colleagues and Santander who have supported us on this journey.\u00a0<\/span>\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Seda are thrilled to announce that we\u00a0have been awarded the Medilink Award for Outstanding Achievement, in recognition of the launch of Seda Clinical Manufacturing Services division with state-of-the-art GMP facility.\u00a0 This inception integrates model-informed formulation design, clinical pharmacology services and GMP manufacturing, creating a seamless service for optimised dosage forms. This innovative integration speeds up…<\/p>\n","protected":false},"author":2,"featured_media":2422,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"categories":[1],"tags":[],"yoast_head":"\n\n\n\n\n\n\n\n\n\n\n\n\n\t\n\t\n\n\n\n\n\t\n